Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by e...
Main Author: | |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English Spanish Portuguese |
Published: |
Pan American Health Organization
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/57104b8d51dc40beb4d465b58a1833fe |
id |
ftdoajarticles:oai:doaj.org/article:57104b8d51dc40beb4d465b58a1833fe |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:57104b8d51dc40beb4d465b58a1833fe 2023-05-15T15:04:31+02:00 Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America Federico Tobar 2008-01-01T00:00:00Z https://doaj.org/article/57104b8d51dc40beb4d465b58a1833fe EN ES PT eng spa por Pan American Health Organization http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 https://doaj.org/article/57104b8d51dc40beb4d465b58a1833fe Revista Panamericana de Salud Pública, Vol 23, Iss 1, Pp 59-67 (2008) formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2008 ftdoajarticles 2022-12-30T22:01:20Z In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English Spanish Portuguese |
topic |
formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Federico Tobar Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
topic_facet |
formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained. |
format |
Article in Journal/Newspaper |
author |
Federico Tobar |
author_facet |
Federico Tobar |
author_sort |
Federico Tobar |
title |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_short |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_full |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_fullStr |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_full_unstemmed |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_sort |
economía de los medicamentos genéricos en américa latina economy of generic drugs in latin america |
publisher |
Pan American Health Organization |
publishDate |
2008 |
url |
https://doaj.org/article/57104b8d51dc40beb4d465b58a1833fe |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista Panamericana de Salud Pública, Vol 23, Iss 1, Pp 59-67 (2008) |
op_relation |
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 https://doaj.org/article/57104b8d51dc40beb4d465b58a1833fe |
_version_ |
1766336283697741824 |